Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Liabilities (2016 - 2025)

Adma Biologics (ADMA) has disclosed Other Non-Current Liabilities for 13 consecutive years, with $90000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 76.0% year-over-year to $90000.0, compared with a TTM value of $90000.0 through Sep 2025, down 76.0%, and an annual FY2024 reading of $360000.0, down 14.08% over the prior year.
  • Other Non-Current Liabilities was $90000.0 for Q3 2025 at Adma Biologics, up from $2000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $789534.0 in Q2 2021 and bottomed at $2000.0 in Q1 2025.
  • Average Other Non-Current Liabilities over 5 years is $346893.3, with a median of $375000.0 recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities soared 821.02% in 2021, then tumbled 99.51% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $397351.0 in 2021, then fell by 11.92% to $350000.0 in 2022, then increased by 19.71% to $419000.0 in 2023, then decreased by 14.08% to $360000.0 in 2024, then crashed by 75.0% to $90000.0 in 2025.
  • Business Quant data shows Other Non-Current Liabilities for ADMA at $90000.0 in Q3 2025, $2000.0 in Q2 2025, and $2000.0 in Q1 2025.